£2.5m to help Newcastle biotech firm launch world-first skin cancer test in the UK and USA
Newcastle Uni spin-out company AMLo Biosciences has received almost £2.5m to help it launch a new skin cancer test which could help reduce the mammoth pressure on the NHS.
Chronicle Live ·